Zelluna, a company developing TCR-NK therapies for cancer, will present its Q4 2025 results via webcast on Feb 12, 2026. The live webcast link will be available on their website at 08:30 CET, with a recording accessible afterwards. The quarterly report and materials will be published at 07:00 CET the same day. For more information, contact Namir Hassan at [email protected] or +44 7720 687608, or Geir Christian Melen at [email protected] or +47 913 02 965. Stay updated on www.zelluna.com for details.

Read more at GlobeNewswire.: Invitation to Fourth Quarter 2025 Results